Article Access statistics

Viewed: 516

Emailed: 0

PDF Downloaded: 205

Journal of Oral Medicine, Oral Surgery, Oral Pathology and Oral Radiology


Central giant cell granuloma: Diagnostic difficulty and multi-stage treatment


Full Text PDF Share on Facebook Share on Twitter


Case Report

Author Details : Rajesh B Dhirawani, Anshika Grover, Sanyog Pathak, Sanchit Jain*

Volume : 5, Issue : 1, Year : 2019

Article Page : 22-25


Suggest article by email

Abstract

The Central Giant Cell Granuloma or CGCG is a fibro-osseous lesion which is considered to be reactive in nature by many authors. Here we are attempting to report a case of CGCG which has been given combination therapy. The combination therapy included local infiltration of corticosteroids along with surgical enucleation of the lesion. The surgical therapy was done after 4 successful administrations of steroids intra-lesionally in clinically aggressive lesion of CGCG. The patient who had been treated by combination therapy has been symptom free from past 3yrs. This combination therapy is hence found to be of adequate success in treating these aggressive lesions which can be addressed without resection of the bone. The morbidity of treatment carried out hence could be reduced a ton. Thereby we are attempting to report and review the treatment protocol for management of such large giant cell lesions which are not so commonly seen in oral and maxillofacial region. The case reported here has been secondarily reconstructed with illiac crest grafting with adequate success.

Keywords: CGCG, Giant Cell lesion, Giant cell Granuloma, Multistage treatment.

Doi : 10.18231/j.jooo.2019.007

How to cite : Dhirawani R B, Grover A, Pathak S, Jain S, Central giant cell granuloma: Diagnostic difficulty and multi-stage treatment. J Oral Med Oral Surg Oral Pathol Oral Radiol 2019;5(1):22-25

Copyright © 2019 by author(s) and J Oral Med Oral Surg Oral Pathol Oral Radiol. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC-BY-NC 4.0) (creativecommons.org)